HL Financial Services LLC raised its holdings in shares of Masimo (NASDAQ:MASI) by 9.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,977 shares of the medical equipment provider’s stock after purchasing an additional 3,260 shares during the quarter. HL Financial Services LLC’s holdings in Masimo were worth $3,340,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Fox Run Management L.L.C. bought a new stake in shares of Masimo during the fourth quarter worth $835,000. Swiss National Bank lifted its position in shares of Masimo by 3.4% during the fourth quarter. Swiss National Bank now owns 84,100 shares of the medical equipment provider’s stock worth $7,132,000 after purchasing an additional 2,800 shares during the last quarter. Alliancebernstein L.P. lifted its position in shares of Masimo by 1.9% during the fourth quarter. Alliancebernstein L.P. now owns 106,691 shares of the medical equipment provider’s stock worth $9,047,000 after purchasing an additional 2,000 shares during the last quarter. Amundi Pioneer Asset Management Inc. bought a new stake in shares of Masimo during the fourth quarter worth $372,000. Finally, Meadow Creek Investment Management LLC lifted its position in shares of Masimo by 24.2% during the fourth quarter. Meadow Creek Investment Management LLC now owns 6,630 shares of the medical equipment provider’s stock worth $562,000 after purchasing an additional 1,292 shares during the last quarter. Institutional investors and hedge funds own 81.03% of the company’s stock.
Get Masimo alerts:
In other Masimo news, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $86.02, for a total value of $172,040.00. Following the transaction, the director now owns 66,249 shares in the company, valued at $5,698,738.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jon Coleman sold 29,303 shares of Masimo stock in a transaction dated Thursday, March 29th. The shares were sold at an average price of $87.50, for a total value of $2,564,012.50. Following the completion of the transaction, the insider now owns 20,504 shares in the company, valued at approximately $1,794,100. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 122,303 shares of company stock worth $11,148,690. Insiders own 12.60% of the company’s stock.
Shares of Masimo stock opened at $97.85 on Friday. The firm has a market cap of $4,751.29, a PE ratio of 39.94, a PEG ratio of 2.41 and a beta of 0.95. Masimo has a 12 month low of $80.69 and a 12 month high of $100.00.
Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, May 2nd. The medical equipment provider reported $0.75 EPS for the quarter, beating the consensus estimate of $0.69 by $0.06. The firm had revenue of $212.90 million for the quarter, compared to analyst estimates of $205.65 million. Masimo had a return on equity of 23.59% and a net margin of 15.99%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.57 earnings per share. analysts forecast that Masimo will post 2.81 EPS for the current year.
Several brokerages have recently commented on MASI. Zacks Investment Research lowered Masimo from a “buy” rating to a “hold” rating in a research note on Tuesday. BidaskClub upgraded Masimo from a “sell” rating to a “hold” rating in a research note on Thursday, March 1st. Piper Jaffray raised their price target on Masimo to $94.00 and gave the company a “neutral” rating in a research note on Wednesday. Barclays began coverage on Masimo in a research note on Friday, March 9th. They set an “overweight” rating and a $97.00 price target on the stock. Finally, BTIG Research restated a “buy” rating and set a $100.00 price target on shares of Masimo in a research note on Thursday. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $102.71.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo (NASDAQ:MASI).